<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><identifier>ir-10054-11742</identifier><datestamp>2011-12-27T05:47:02Z</datestamp><dc:title>Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu-I, Au-I) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line</dc:title><dc:creator>SURESH, D</dc:creator><dc:creator>BALAKRISHNA, MS</dc:creator><dc:creator>RATHINASAMY, K</dc:creator><dc:creator>PANDA, D</dc:creator><dc:creator>MAGUE, JT</dc:creator><dc:subject>sulfur donor action</dc:subject><dc:subject>catalytic asymmetric hydrogenation</dc:subject><dc:subject>copper(ii) complex</dc:subject><dc:subject>platinum complexes</dc:subject><dc:subject>antitumor-activity</dc:subject><dc:subject>cyclic silanes</dc:subject><dc:subject>dna-damage</dc:subject><dc:subject>drugs</dc:subject><dc:subject>chemistry</dc:subject><dc:subject>cyclodiphosphazane</dc:subject><dc:description>The large-bite bis(phosphite) ligand [{(-OC10H6(mu-S)C10H6O-)P{mu-(-OC10H6(mu-S)C10H6O-)}-P( -OC10H6(mu-S)C10H6O-)}] ((PP)-P-Lambda) (2) was obtained by the reaction of PCl3 and thiobis(2,2'-naphthol) (1). The stoichiometric reactions of 2 with elemental sulfur and selenium afforded the corresponding chalcogenide derivatives [(E) (PP)-P-Lambda(E)] (3, E = S; 4, E = Se) in good yield. Treatment of two equivalents of [ClAu(SMe2)] with 2 afforded a dinuclear complex [ClAu((PP)-P-Lambda)AuCl] (5), whereas the 1 : 1 reaction with CuI yielded the [((PP)-P-Lambda)CuI] (6) complex. The copper(I) complex 6 on treatment with various pyridyl derivatives, produced mixed-ligand complexes [((PP)-P-Lambda)CuI(NC5H5)] (7), [((PP)-P-Lambda)Cu(2,2'-bpy)]I (8), [((PP)-P-Lambda)Cu(1,10-phen)]I (9) and {[((PP)-P-Lambda)Cu(4,4'-bpy)]I}(infinity) (10). The compounds 2-5 were tested for their cytotoxic activity on the human cervical cancer (HeLa) cell line. Compounds 2 and 3 were found to inhibit proliferation of HeLa cells significantly. These agents also induced apoptotic cell death in cancer cells. Evidence presented in this study indicated that the compounds 2 and 3 activate the tumor suppressor protein p53 in the colon adenocarcinoma (HCT-116) cell line.</dc:description><dc:publisher>ROYAL SOC CHEMISTRY</dc:publisher><dc:date>2011-08-28T12:48:46Z</dc:date><dc:date>2011-12-26T12:58:02Z</dc:date><dc:date>2011-12-27T05:47:02Z</dc:date><dc:date>2011-08-28T12:48:46Z</dc:date><dc:date>2011-12-26T12:58:02Z</dc:date><dc:date>2011-12-27T05:47:02Z</dc:date><dc:date>2008</dc:date><dc:type>Article</dc:type><dc:identifier>DALTON TRANSACTIONS, (17), 2285-2292</dc:identifier><dc:identifier>1477-9226</dc:identifier><dc:identifier>http://dx.doi.org/10.1039/b719904j</dc:identifier><dc:identifier>http://dspace.library.iitb.ac.in/xmlui/handle/10054/11742</dc:identifier><dc:identifier>http://hdl.handle.net/10054/11742</dc:identifier><dc:language>en</dc:language></oai_dc:dc>